Sign in

CIK 0001528115

  • Non-accelerated filer
  • Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
275414423
Phone
+1 650-822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 6,912 shares at $2.92 ($20,183)
  2. 4 Open-market sale PRESIDENT AND CEO sold 5,021 shares at $2.95 ($14,812)
  3. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,786 shares at $2.98 ($5,322)
  4. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,425 shares at $2.99 ($4,261)
  5. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,783 shares at $2.99 ($5,331)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Option exercise PRESIDENT AND CEO acquired 37,994 shares (option exercise)
  9. 4 Open-market buy Director bought 3,200 shares at $5.33 ($17,056)
  10. 4 Option exercise PRESIDENT AND CEO acquired 114,449 shares (option exercise)
  11. 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,408 shares at $7.41 ($40,073)
  12. 4 Open-market buy Director bought 3,200 shares at $5.97 ($19,104)
  13. 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 4,500 shares at $7.10 ($31,950)
  14. 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $6.16 ($33,880)
  15. 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $5.64 ($31,020)
  16. 4 Open-market buy Director bought 3,200 shares at $5.48 ($17,536)
  17. 4 Planned sale EVP & CHIEF INNOVATION OFFICER sold 5,500 shares at $5.95 ($32,725)
  18. 4 Open-market buy Director bought 3,200 shares at $6.24 ($19,968)
  19. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 784 shares at $6.02 ($4,720)
  20. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,104 shares at $6.03 ($6,657)

Page 4 of 11 · 206 filings